MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy. Constanzo J, Parach A, David T, Karam J, et al. J Nucl Med 2025 Feb 27:jnumed.124.268857. doi: 10.2967/jnumed.124.268857.

Read + Share

Amedeo Smart

Independent Medical Education

Constanzo J, Parach A, David T, Karam J, et al. MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy. J Nucl Med 2025 Feb 27:jnumed.124.268857. doi: 10.2967/jnumed.124.268857.
PMID: 40015918